產(chǎn)品[
CA46 Burkitts 人**瘤細胞系
]資料
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱:
CA46 Burkitts 人**瘤細胞系
產(chǎn)品型號:
CRL-1648
產(chǎn)品廠商:
美國標準生物品收藏中心（ATCC）
產(chǎn)品文檔:
無相關(guān)文檔
簡單介紹
CRL-1648 CA46 Burkitts 人**瘤細胞系，原代細胞|細胞系|細胞株|菌種；細胞庫管理規(guī)范，提供的細胞株背景清楚，提供參考文獻和培養(yǎng)條件！
CA46 Burkitts 人**瘤細胞系
的詳細介紹
CRL-1648 CA46 Burkitts 人**瘤細胞系
|
|
CRL-1648?
|
|
$399.00
|
|
|
CA46
|
|
|
IT Magrath
|
|
|
IgM; kappa light chain
|
|
Biosafety Level:
|
1
|
|
|
frozen
|
|
Medium & Serum:
|
See Propagation
|
|
|
suspension
|
|
|
Homo sapiens (human)
|
|
|
lymphoblast
|
|
|
Disease: Burkitt's lymphoma
Cell Type: B lymphocyte;
|
|
|
immunoglobulin (surface and secreted)
|
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
|
|
complement
|
|
|
HLA B27 (the patient was HLA A2, A11, B17, B27)
|
|
|
Amelogenin: X
CSF1PO: 10,12
D13S317: 8,12
D16S539: 11,12
D5S818: 13
D7S820: 11,12
THO1: 7,9
TPOX: 8,9
vWA: 15,16
|
|
|
46, XO, XY, dup1(q21-32), t(8;14) (8pter --> 8q23 :: 14q32 --> 14qter; 14pter --> 14q32 :: 8q23 --> 8qter), 13q+, +16
|
|
|
male
|
|
|
ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
Temperature: 37.0°C
|
|
|
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 10 exp5 viable cells/ml.
A saturation density of 2 X 10 exp6 is obtainable.
|
|
|
culture medium 95%; DMSO, 5%
|
|
